Anpario Plc Cash Flow Conversion Efficiency
Anpario Plc cash flow conversion efficiency. Based on the latest financial reports, Anpario Plc (ANP) has a cash flow conversion efficiency ratio of 0.112x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX4.58 Million ≈ $557.13 USD) by net assets (GBX40.96 Million ≈ $4.98K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Anpario Plc (2002–2025)
Cash flow conversion efficiency of Anpario Plc from 2002 to 2025. This chart illustrates how Anpario Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ANP share price today for real-time trading data and today's change.
Anpario Plc Cash Flow Conversion Ratio Explained
Anpario Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Anpario Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anpario Plc ranked by their cash flow conversion efficiency. Also see Anpario Plc (ANP) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alligator Bioscience AB
ST:ATORX
|
-4.204x |
|
Antarctica Limited
NSE:ANTGRAPHIC
|
0.098x |
|
BioNeutra Global Corp
V:BGA
|
-0.004x |
|
PHAXIAM Therapeutics S.A.
PA:PHXM
|
-0.540x |
|
Quintegra Solutions Limited
NSE:QUINTEGRA
|
0.000x |
|
Fram Skandinavien AB Series B
ST:FRAM-B
|
-2.899x |
|
Sarawak Cable Bhd
KLSE:5170
|
0.002x |
|
4BASEBIO UK SOCIETAS
LSE:4BB
|
-0.703x |
Annual Cash Flow Conversion Efficiency for Anpario Plc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Anpario Plc from 2002 to 2025. Review Anpario Plc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX40.96 Million ≈ $4.98K |
GBX6.02 Million ≈ $732.82 |
0.147x | -8.67% |
| 2024-12-31 | GBX36.29 Million ≈ $4.42K |
GBX5.84 Million ≈ $710.92 |
0.161x | -37.70% |
| 2023-12-31 | GBX33.65 Million ≈ $4.09K |
GBX8.70 Million ≈ $1.06K |
0.258x | +882.05% |
| 2022-12-31 | GBX41.31 Million ≈ $5.03K |
GBX1.09 Million ≈ $132.26 |
0.026x | -66.28% |
| 2021-12-31 | GBX40.30 Million ≈ $4.90K |
GBX3.15 Million ≈ $382.66 |
0.078x | -49.80% |
| 2020-12-31 | GBX37.51 Million ≈ $4.56K |
GBX5.83 Million ≈ $709.34 |
0.155x | +39.21% |
| 2019-12-31 | GBX35.55 Million ≈ $4.33K |
GBX3.97 Million ≈ $483.03 |
0.112x | +37.65% |
| 2018-12-31 | GBX33.15 Million ≈ $4.03K |
GBX2.69 Million ≈ $327.17 |
0.081x | -52.69% |
| 2017-12-31 | GBX30.52 Million ≈ $3.71K |
GBX5.23 Million ≈ $636.83 |
0.171x | +28.85% |
| 2016-12-31 | GBX28.54 Million ≈ $3.47K |
GBX3.80 Million ≈ $462.11 |
0.133x | +4.24% |
| 2015-12-31 | GBX26.58 Million ≈ $3.23K |
GBX3.39 Million ≈ $412.95 |
0.128x | -10.56% |
| 2014-12-31 | GBX22.75 Million ≈ $2.77K |
GBX3.25 Million ≈ $395.07 |
0.143x | -1.70% |
| 2013-12-31 | GBX20.13 Million ≈ $2.45K |
GBX2.92 Million ≈ $355.64 |
0.145x | +19.68% |
| 2012-12-31 | GBX17.89 Million ≈ $2.18K |
GBX2.17 Million ≈ $264.03 |
0.121x | -3.65% |
| 2011-12-31 | GBX16.00 Million ≈ $1.95K |
GBX2.02 Million ≈ $245.17 |
0.126x | +83.64% |
| 2010-12-31 | GBX14.79 Million ≈ $1.80K |
GBX1.01 Million ≈ $123.37 |
0.069x | -55.15% |
| 2009-12-31 | GBX13.61 Million ≈ $1.66K |
GBX2.08 Million ≈ $253.08 |
0.153x | +166.70% |
| 2008-12-31 | GBX7.54 Million ≈ $916.91 |
GBX432.00K ≈ $52.56 |
0.057x | -37.23% |
| 2007-12-31 | GBX7.13 Million ≈ $867.27 |
GBX651.00K ≈ $79.21 |
0.091x | +137.05% |
| 2006-12-31 | GBX6.76 Million ≈ $822.74 |
GBX-1.67 Million ≈ $-202.83 |
-0.247x | +15.15% |
| 2005-12-31 | GBX1.86 Million ≈ $226.55 |
GBX-541.00K ≈ $-65.82 |
-0.291x | +62.61% |
| 2004-12-31 | GBX619.00K ≈ $75.31 |
GBX-481.00K ≈ $-58.52 |
-0.777x | -109.73% |
| 2003-12-31 | GBX-61.00K ≈ $-7.42 |
GBX-487.00K ≈ $-59.25 |
7.984x | -89.29% |
| 2002-12-31 | GBX-15.00K ≈ $-1.83 |
GBX-1.12 Million ≈ $-136.03 |
74.533x | -- |
About Anpario Plc
Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and fee… Read more